1. |
Wilhelm H, Schabet M. The diagnosis and treatment of optic neuritis[J]. Dtsch Arztebl Int, 2015, 112(37): 616-626. DOI: 10.3238/arztebl.2015.0616.
|
2. |
中華醫學會眼科分學會神經眼科學組, 蘭州大學循證醫學中心/世界衛生組織指南實施與知識轉化合作中心. 中國脫髓鞘性視神經炎診斷和治療循證指南(2021年)[J]. 中華眼科雜志, 2021, 57(3): 171-186. DOI: 10.3760 /cma.j.cn 112142-20201124-00769.Neuro-ophthalmology Group of Ophthalmology Branch of Chinese Medical Association, Evidence-based Medicine Center of LanzhouUniversity/World Health Organization Collaborating Centre for Guideline Implementation and Knowledge Translation. Evidence based guidelines for diagnosis and treatment of demyelinating optic neuritis in China (2021)[J]. Chin J Ophthalmol, 2021, 57(3): 171-186. DOI: 10.3760 /cma.j.cn 112142-20201124-00769.
|
3. |
Fujihara K. Neuromyelitis optica and astrocytic damage in its pathogenesis[J]. J Neurol Sci, 2011, 306(1-2): 183-187. DOI: 10.1016/j.jns.2011.02.018.
|
4. |
Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study[J]. Neurology, 2010, 75(3): 208-216. DOI: 10.1212/WNL.0b013e3181e2414b.
|
5. |
宋宏魯, 魏世輝, 孫明明, 等. 《中國脫髓鞘性視神經炎診斷和治療循證指南(2021年)》解讀[J]. 中華眼底病雜志, 2021, 37(10): 753-757. DOI: 10.3760/cma.j.cn511434-20210830-00475.Song HL, Wei SH, Sun MM, et al. Interpretation of an evidence-based guideline for the diagnosis and treatment of demyelinating optic neuritis in China (2021)[J]. Chin J Ocul Fundus Dis, 2021, 37(10): 753-757. DOI: 10.3760/cma.j.cn511434-20210830-00475.
|
6. |
Saadoun S, Papadopoulos MC. Role of membrane complement regulators in neuromyelitis optical[J]. Mult Scler, 2015, 21(13): 1644-1654. DOI: 10.1177/1352458515571446.
|
7. |
Quek AM, McKeon A, Lennon VA, et al. Effects of age and sex on aquaporin-4 autoimmunity[J]. Arch Neurol, 2012, 69(8): 1039-1043. DOI: 10.1001/ archneurol.2012.249. DOI: 10.1001/archneurol.2012.249.
|
8. |
中華醫學會眼科學分會神經眼科學組. 視神經炎診斷和治療專家共識(2014年)[J]. 中華眼科雜志, 2014, 50(6): 459-463. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013.Neuroophthalmology Group, Society of Ophthalmology, Chinese Medical Association. Expert consensus on the diagnosis and treatment of optic neuritis (2014)[J]. Chin J Ophthalmol, 2014, 50(6): 459-463. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013.
|
9. |
Issa N, Martin C, Dulau C, et al. Severe anti-GFAP meningo-encephalomyelitis following viral infection[J/OL]. Mult Scler Relat Disord, 2020, 45: 102448[2020-08-19]. https://pubmed.ncbi.nlm.nih.gov/32827972/. DOI: 10.1016/j.msard.2020.102448.
|
10. |
Handoko M, Hong W, Espineli E, et al. Autoimmune glial fibrillary acidic protei-n astrocytopathy following herpes simplex virus encephalitis in a pediatric patient[J]. Pediatr Neurol, 2019, 98: 85-86. DOI: 10.1016/j.pediatrneurol.2019.05.010.
|
11. |
Long Y, Liang J, Xu H, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study[J]. Eur J Neurol, 2018, 25(3): 477-483. DOI: 10.1111/ene.13531.
|
12. |
Fang B, McKeon. A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoen-cephalomyelitis[J]. JAMA Neurol, 2016, 73(11): 1297-1307. DOI: 10.1001/jamaneurol.2016.2549.
|
13. |
高豐, 劉華. 自身免疫性膠質纖維酸性蛋白星形細胞病的研究進展[J]. 中風與神經疾病雜志, 2021, 38(4): 383-384. DOI: 10.19845/j.cnki.zfysjjbzz.2021.0103.Gao F, Liu H. Advances in the study of autoimmune glial fibrillary acidic protein astrocytoma[J]. J Apoplexy and Nervous Diseases, 2021, 38(4): 383-384. DOI: 10.19845/j.cnki.zfysjjbzz.2021.0103.
|
14. |
Flanagan EP, Hinson SR, Lennon VA, et al. GFAP-IgG as biomarker of autoimmune astrocytopathy: analysis of 102 patients[J]. Ann Neurol, 2017, 81(2): 298-309. DOI: 10.1002/ana.24881.
|
15. |
Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders[J]. Nat Rev Neurol, 2022, 18(3): 158-172. DOI: 10.1038/s41582-021-00616-3.
|
16. |
Storoni M, Petzold A, Plant GT. The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis[J/OL]. PLoS One, 2011, 6(8): e23489[2011-08-18]. https://pubmed.ncbi.nlm.nih.gov/21876753/. DOI: 10.1371/journal.pone.0023489.
|
17. |
Storoni M, Verbeek MM, Illes Z, et al. Serum GFAP levels in optic neuropathies[J]. J Neurol Sci, 2012, 317(1-2): 117-122. DOI: 10.1016/j.jns.2012.02.012.
|
18. |
中國免疫學會神經免疫學分會, 中華醫學會神經病學分會神經免疫學組, 中國醫師協會神經內科分會神經免疫專業委員會. 中國視神經脊髓炎譜系疾病診斷與治療指南[J]. 中國神經免疫學和神經病學雜志, 2016, 23(3): 155-165. DOI: 10.3969/j.issn.1006-2963.2016.03.001.Neuroimmunology Branch of Chinese Society of Immunology, Neuroimmunology Group of Neurology Branch of Chinese Medical Association, Neuroimmunology Professional Committee of Neurology Branch of Chinese Medical Doctor Association, Chinese Medical Doctor Association. Guidelines for diagnosis and treatment of neuromyelitis spectrum diseases in China[J]. Chin J Neuroimmunol & Neurol, 2016, 23(3): 155-165. DOI: 10.3969/j.issn.1006-2963.2016.03.001.
|